Tech Company Financing Transactions

Ivantis Funding Round

Ivantis, based in Irvine, received $25 million from Ascension Ventures, Delphi Ventures and EDB Investments.

Transaction Overview

Company Name
Ivantis
Announced On
9/23/2014
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Series B
Investors

Ascension Ventures (Tara Butler)

Delphi Ventures (Douglas Roeder)

EDB Investments (Thong-Yuen Poon)

Foresite Capital (James Tananbaum)

GBS Venture Partners (Benjamin Gust)

MemorialCare Innovation Fund

New Enterprise Associates (Jay Graf)

Vertex Venture Capital (Lincoln Chee)

Proceeds Purpose
The funds will support the Company's multiple ongoing clinical trials, including the US pivotal trial, and is expected to take the Company through U.S. approval.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
201 Technology
Irvine, CA 92618
USA
Phone
(949) 333-1332
Website
www.ivantisinc.com
Email Address
[email protected]
Overview
Ivantis, Inc. is a company dedicated to the development of new and innovative solutions for glaucoma. Current therapies for primary open angle glaucoma (POAG) include eye drops, laser therapy, and surgery.
Profile
Ivantis LinkedIn Company Profile
Social Media
Ivantis Company Twitter Account
Company News
Ivantis News
Facebook
Ivantis on Facebook
YouTube
Ivantis on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Dave Meter
  Dave Meter LinkedIn Profile  Dave Meter Twitter Account  Dave Meter News  Dave Meter on Facebook
Chief Scientific Officer
Brett Trauthen
  Brett Trauthen LinkedIn Profile  Brett Trauthen Twitter Account  Brett Trauthen News  Brett Trauthen on Facebook
VP - Marketing
Michael Chodzko
  Michael Chodzko LinkedIn Profile  Michael Chodzko Twitter Account  Michael Chodzko News  Michael Chodzko on Facebook
VP - Operations
Todd Abraham
  Todd Abraham LinkedIn Profile  Todd Abraham Twitter Account  Todd Abraham News  Todd Abraham on Facebook
VP - R & D
Ken Galt
  Ken Galt LinkedIn Profile  Ken Galt Twitter Account  Ken Galt News  Ken Galt on Facebook
VP - Regulatory Affairs
Helene Spencer
  Helene Spencer LinkedIn Profile  Helene Spencer Twitter Account  Helene Spencer News  Helene Spencer on Facebook
VP - Sales
Frank Shields
  Frank Shields LinkedIn Profile  Frank Shields Twitter Account  Frank Shields News  Frank Shields on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/23/2014: PicnicHealth venture capital transaction
Next: 9/23/2014: NexSteppe venture capital transaction

 

Share this article

 

News on VC Transactions

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.